Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections
A collaborative project financed by the EC Framework Programme 7
Oxford University is one of the leading research intensive academic institutions in the world.
T cell immunity to viral pathogens is a major focus of this research. The institution has made significant investment in "bench to bedside" vaccine research over the last 15 years, with the establishment of the Centre for Clinical Vaccinology, the Jenner Institute and a clinical biomanufacturing facility.
Large and diverse research groups are based within the Nuffield Department of Medicine Research Building, the Peter Medawar Building for Pathogen Research and the Jenner Institute.
The Medical Sciences Division is internationally recognised for excellence in biomedical research, particularly in Infection and Immunity